[KLK] YoY Cumulative Quarter Result on 30-Sep-2016 [#4]

Announcement Date
16-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2016
Quarter
30-Sep-2016 [#4]
Profit Trend
QoQ- 30.81%
YoY- 83.03%
View:
Show?
Cumulative Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 15,533,887 18,400,500 21,004,036 16,505,810 13,649,991 11,129,973 9,147,325 9.22%
PBT 823,928 1,117,380 1,450,205 1,712,284 1,134,598 1,317,697 1,199,767 -6.06%
Tax -173,195 -313,276 -383,329 -29,144 -250,560 -285,003 -232,797 -4.80%
NP 650,733 804,104 1,066,876 1,683,140 884,038 1,032,694 966,970 -6.38%
-
NP to SH 617,505 753,328 1,005,130 1,592,191 869,912 991,705 917,743 -6.38%
-
Tax Rate 21.02% 28.04% 26.43% 1.70% 22.08% 21.63% 19.40% -
Total Cost 14,883,154 17,596,396 19,937,160 14,822,670 12,765,953 10,097,279 8,180,355 10.48%
-
Net Worth 10,362,115 11,427,081 11,576,176 10,447,313 9,668,055 7,752,950 7,529,307 5.46%
Dividend
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Div 159,744 159,744 532,482 532,482 479,143 585,731 532,482 -18.17%
Div Payout % 25.87% 21.21% 52.98% 33.44% 55.08% 59.06% 58.02% -
Equity
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Net Worth 10,362,115 11,427,081 11,576,176 10,447,313 9,668,055 7,752,950 7,529,307 5.46%
NOSH 1,064,965 1,064,965 1,064,965 1,064,965 1,064,763 1,064,965 1,064,965 0.00%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 4.19% 4.37% 5.08% 10.20% 6.48% 9.28% 10.57% -
ROE 5.96% 6.59% 8.68% 15.24% 9.00% 12.79% 12.19% -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 1,458.63 1,727.80 1,972.27 1,549.89 1,281.97 1,045.10 858.93 9.22%
EPS 58.00 70.70 94.40 149.50 81.70 93.10 86.20 -6.38%
DPS 15.00 15.00 50.00 50.00 45.00 55.00 50.00 -18.17%
NAPS 9.73 10.73 10.87 9.81 9.08 7.28 7.07 5.46%
Adjusted Per Share Value based on latest NOSH - 1,064,965
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 1,413.47 1,674.31 1,911.22 1,501.91 1,242.05 1,012.75 832.34 9.22%
EPS 56.19 68.55 91.46 144.88 79.16 90.24 83.51 -6.38%
DPS 14.54 14.54 48.45 48.45 43.60 53.30 48.45 -18.16%
NAPS 9.4288 10.3978 10.5335 9.5063 8.7972 7.0546 6.8511 5.46%
Price Multiplier on Financial Quarter End Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 -
Price 23.08 24.96 24.56 23.98 21.70 21.08 22.60 -
P/RPS 1.58 1.44 1.25 1.55 1.69 2.02 2.63 -8.13%
P/EPS 39.80 35.29 26.02 16.04 26.56 22.64 26.23 7.19%
EY 2.51 2.83 3.84 6.23 3.76 4.42 3.81 -6.71%
DY 0.65 0.60 2.04 2.09 2.07 2.61 2.21 -18.44%
P/NAPS 2.37 2.33 2.26 2.44 2.39 2.90 3.20 -4.87%
Price Multiplier on Announcement Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 19/11/19 14/11/18 22/11/17 16/11/16 18/11/15 19/11/14 20/11/13 -
Price 22.50 24.92 24.50 23.92 22.68 23.00 24.00 -
P/RPS 1.54 1.44 1.24 1.54 1.77 2.20 2.79 -9.42%
P/EPS 38.80 35.23 25.96 16.00 27.76 24.70 27.85 5.67%
EY 2.58 2.84 3.85 6.25 3.60 4.05 3.59 -5.35%
DY 0.67 0.60 2.04 2.09 1.98 2.39 2.08 -17.19%
P/NAPS 2.31 2.32 2.25 2.44 2.50 3.16 3.39 -6.19%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment